Dusa Pharmaceuticals

Rediff.com » News » Dusa Pharmaceuticals

News for Dusa Pharmaceuticals

Business

Sun Pharma arm settles case with Biofrontera, to get $22.5 mn

Sun Pharmaceutical Industries on Tuesday said its arm DUSA Pharmaceuticals Inc has reached settlement with Biofrontera to resolve a litigation over misappropriation of trade secrets and unfair......

Sun Pharma to acquire US-based DUSA for $230 million

Sun Pharmaceutical Industries on Thursday said it has inked a pact to acquire US-based DUSA Pharmaceuticals for around $230 million (around Rs 1,250 crore).Sun Pharma and DUSA Pharmaceuticals have......

Benefit of Ranbaxy deal to accrue in few years: Sun Pharma

It will take a ‘few years’ for Sun Pharma to realise the benefits of its $4 billion takeover of Ranbaxy, said the company's Chairman Israel Makov, terming the deal as a ‘complex......

Sun Pharma keen to enter Japan's generics market

Sun Pharmaceutical Industries Ltd, India's biggest drugmaker by market value, is looking for partnerships or acquisitions to enter Japan, an especially lucrative market for manufacturers of......

Sun Pharma in talks to buy Meda for $5-$6 billion

Sun Pharmaceutical Industries Ltd is in talks to buy Swedish drugmaker MedaAB for $5 billion-$6 billion to boost its generics business in developed markets, two sources with direct knowledge of the......

Rediff News

Dusa Pharmaceuticals

News for Dusa Pharmaceuticals

Sun Pharma arm settles case with Biofrontera, to get $22.5 mn

Sun Pharma to acquire US-based DUSA for $230 million

Benefit of Ranbaxy deal to accrue in few years: Sun Pharma

Sun Pharma keen to enter Japan's generics market

Sun Pharma in talks to buy Meda for $5-$6 billion

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS